High-level production of animal-free recombinant transferrin from saccharomyces cerevisiae

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Finnis, Christopher J A ^a   Payne, Tom ^a   Hay, Joanna ^a   Dodsworth, Neil ^a   Wilkinson, Diane ^a   Morton, Philip ^a   Saxton, Malcolm J ^a   Tooth, David J ^b   Evans, Robert W ^c   Goldenberg, Hans ^d   Scheiber Mojdehkar, Barbara ^d   Ternes, Nina ^d   Sleep, Darrell ^a  

^a Novozymes Biopharma DK A S   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUFUSE; HUMAN ALBUMIN; HYBRID PROTEIN; PROTEIN DISULFIDE ISOMERASE; RECOMBINANT PROTEIN; RECOMBUMIN; TRANSFERRIN; UNCLASSIFIED DRUG; CHAPERONE;

ARTICLE; EXPRESSION VECTOR; FED BATCH FERMENTATION; GENE EXPRESSION SYSTEM; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE; BIOSYNTHESIS; CELL COUNT; CHEMISTRY; FERMENTATION; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM;

ANIMALIA; SACCHAROMYCES CEREVISIAE;

CELL COUNT; FERMENTATION; GLYCOSYLATION; HUMANS; MOLECULAR CHAPERONES; PROTEIN DISULFIDE-ISOMERASES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; TRANSFERRIN;

EID: 78349281567     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-87     Document Type: Article

References (37)

1. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002, 22(3):225-250. 10.1002/med.10008, 11933019.
2. Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today 2005, 10(4):267-273. 10.1016/S1359-6446(04)03333-1, 15708745.
3. Weinberg ED. Therapeutic potential of human transferrin and lactoferrin. ASM News 2002, 68(2):65-69.
4. Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. Am J Hum Genet 1993, 53(1):201-213. 1682235, 8317485.
5. Li H, Rybicki AC, Suzuka SM, von Bonsdorff L, Breuer W, Hall CB, Cabantchik ZI, Bouhassira EE, Fabry ME, Ginzburg YZ. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med 2010, 16(2):177-182. 10.1038/nm.2073, 20098432.
6. Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Br J Haematol 2002, 119(2):547-553. 10.1046/j.1365-2141.2002.03836.x, 12406099.
7. von Bonsdorff L, Tolo H, Lindeberg E, Nyman T, Harju A, Parkkinen J. Development of a pharmaceutical apotransferrin product for iron binding therapy. Biologicals 2001, 29(1):27-37. 10.1006/biol.2001.0273, 11482890.
8. de Vries B, Walter SJ, von Bonsdorff L, Wolfs TG, van Heurn LW, Parkkinen J, Buurman WA. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 2004, 77(5):669-675. 10.1097/01.TP.0000115002.28575.E7, 15021827.
9. Bai Y, Ann DK, Shen WC. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci USA 2005, 102(20):7292-7296. 10.1073/pnas.0500062102, 1129103, 15870205.
10. Amet N, Wang W, Shen WC. Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release 2010, 141(2):177-182. 10.1016/j.jconrel.2009.09.007, 19761807.
11. Schmidt SR. Fusion-proteins as biopharmaceuticals - applications and challenges. Curr Opin Drug Discov Devel 2009, 12(2):284-295.
12. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001, 47(1):13-27.
13. Mason AB, Miller MK, Funk WD, Banfield DK, Savage KJ, Oliver RW, Green BN, MacGillivray RT, Woodworth RC. Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins. Biochemistry 1993, 32(20):5472-5479. 10.1021/bi00071a025, 8499451.
14. MacGillivray RTA, Mason AB. Transferrins. Molecular and Cellular Iron Transport 2002, 41-69. Marcel Dekker, Inc., Templeton DM.
15. Mizutani K, Hashimoto K, Takahashi N, Hirose M, Aibara S, Mikami B. Structural and functional characterization of recombinant human serum transferrin secreted from Pichia pastoris. Biosci Biotechnol Biochem 2010, 74(2):309-315. 10.1271/bbb.90635, 20139607.
16. Mukaiyama H, Tohda H, Takegawa K. Overexpression of protein disulfide isomerases enhances secretion of recombinant human transferrin in Schizosaccharomyces pombe. Appl Microbiol Biotechnol 2010, 86(4):1135-1143. 10.1007/s00253-009-2393-x, 20013338.
17. Brandsma ME, Diao H, Wang X, Kohalmi SE, Jevnikar AM, Ma S. Plant-derived recombinant human serum transferrin demonstrates multiple functions. Plant Biotechnol J 2010, 8(4):489-505. 10.1111/j.1467-7652.2010.00499.x, 20432512.
18. Zhang D, Nandi S, Bryan P, Pettit S, Nguyen D, Santos MA, Huang N. Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.). Protein Expr Purif 2010, 74(1):69-79. 10.1016/j.pep.2010.04.019, 20447458.
19. Sleep D, Belfield GP, Ballance DJ, Steven J, Jones S, Evans LR, Moir PD, Goodey AR. Saccharomyces cerevisiae strains that overexpress heterologous proteins. Biotechnology (N Y) 1991, 9(2):183-187. 10.1038/nbt0291-183, 1367516.
20. Sleep D, Finnis C, Turner A, Evans L. Yeast 2 micron plasmid copy number is elevated by a mutation in the nuclear gene UBC4. Yeast 2001, 18(5):403-421. 10.1002/yea.679, 11255249.
21. Kerry-Williams SM, Gilbert SC, Evans LR, Ballance DJ. Disruption of the Saccharomyces cerevisiae YAP3 gene reduces the proteolytic degradation of secreted recombinant human albumin. Yeast 1998, 14(2):161-169. 10.1002/(SICI)1097-0061(19980130)14:2<161::AID-YEA208>3.0.CO;2-Y, 9483804.
22. Sleep D, Finnis C, Evans L. Enhanced protein expression through strain selection, gene disruption, improved vector design and co-expression of endogenous chaperones. Microb Cell Fact 2006, 5(Suppl 1):S29.
23. Chinery SA, Hinchliffe E. A novel class of vector for yeast transformation. Curr Genet 1989, 16(1):21-25. 10.1007/BF00411079, 2676207.
24. Robinson AS, Hines V, Wittrup KD. Protein disulfide isomerase overexpression increases secretion of foreign proteins in Saccharomyces cerevisiae. Biotechnology (N Y) 1994, 12(4):381-384. 10.1038/nbt0494-381, 7764684.
25. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, Giuliani M, Parrilli E, Branduardi P, Lang C, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11. 10.1186/1475-2859-7-11, 2322954, 18394160.
26. Keenan J, Pearson D, O'Driscoll L, Gammell P, Clynes M. Evaluation of recombinant human transferrin (DeltaFerrin™) as an iron chelator in serum-free media for mammalian cell culture. Cytotechnology 2006, 51(1):29-37. 10.1007/s10616-006-9011-x, 19002892.
27. Sargent PJ, Farnaud S, Cammack R, Zoller HM, Evans RW. Characterisation of recombinant unglycosylated human serum transferrin purified from Saccharomyces cerevisiae. Biometals 2006, 19(5):513-519. 10.1007/s10534-005-5532-6, 16937257.
28. Liang Q, Richardson T. Expression and characterization of human lactoferrin in yeast Saccharomyces cerevisiae. J Agric Food Chem 1993, 41:1800-1807.
29. Bewley MC, Tam BM, Grewal J, He S, Shewry S, Murphy ME, Mason AB, Woodworth RC, Baker EN, MacGillivray RT. X-ray crystallography and mass spectroscopy reveal that the N-lobe of human transferrin expressed in Pichia pastoris is folded correctly but is glycosylated on serine-32. Biochemistry 1999, 38(8):2535-2541. 10.1021/bi9824543, 10029548.
30. Limke T, Cunningham M, Chirkova L, Voorhamme D, Standfield S, Cavallaro D. CellPrime™ recombinant human transferrin as an animal-free alternative to animal-derived transferrin or iron supplementation in cell culture applications. BioProcess International 6(7):164-165.
31. Sleep D, Belfield GP, Goodey AR. The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences. Biotechnology (N Y) 1990, 8(1):42-46. 10.1038/nbt0190-42, 1366511.
32. Farquhar R, Honey N, Murant SJ, Bossier P, Schultz L, Montgomery D, Ellis RW, Freedman RB, Tuite MF. Protein disulfide isomerase is essential for viability in Saccharomyces cerevisiae. Gene 1991, 108(1):81-89. 10.1016/0378-1119(91)90490-3, 1761235.
33. Collins SH. Production of secreted proteins in yeast. Protein production by biotechnology 1990, 61-77. London: Elsevier, Harris TJR.
34. Makey DG, Seal US. The detection of four molecular forms of human transferrin during the iron binding process. Biochim Biophys Acta 1976, 453(1):250-256.
35. Bates GW, Schlabach MR. The reaction of ferric salts with transferrin. J Biol Chem 1973, 248(9):3228-3232.
36. Rine J, Strathern JN, Hicks JB, Herskowitz I. A suppressor of mating-type locus mutations in Saccharomyces cerevisiae: evidence for and identification of cryptic mating-type loci. Genetics 1979, 93(4):877-901. 1214119, 397913.
37. Payne T, Finnis C, Evans LR, Mead DJ, Avery SV, Archer DB, Sleep D. Modulation of chaperone gene expression in mutagenized Saccharomyces cerevisiae strains developed for recombinant human albumin production results in increased production of multiple heterologous proteins. Appl Environ Microbiol 2008, 74(24):7759-7766. 10.1128/AEM.01178-08, 2607181, 18931293.